Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression.

Llano A, Barretina J, Gutiérrez A, Clotet B, Esté JA.

J Virol. 2003 Apr;77(7):4389-95.

2.
3.

Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.

Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):122-31.

PMID:
11832680
4.
5.

Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.

Blanco J, Cabrera C, Jou A, Ruiz L, Clotet B, Esté JA.

AIDS. 1999 Apr 1;13(5):547-55.

PMID:
10203379
7.
8.

Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.

Carter LM, Peters BS, Ellis BA, Wolstencroft RA.

J Infect. 2000 Nov;41(3):252-5.

PMID:
11120614
9.

Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.

Boulassel MR, Smith GH, Edwardes MD, Young M, Klein M, Gilmore N, Macleod J, Leblanc R, René P, Allan J, Lalonde RG, Routy JP.

HIV Med. 2005 Jul;6(4):268-77.

10.

IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.

Losana G, Bovolenta C, Rigamonti L, Borghi I, Altare F, Jouanguy E, Forni G, Casanova JL, Sherry B, Mengozzi M, Trinchieri G, Poli G, Gerosa F, Novelli F.

J Leukoc Biol. 2002 Oct;72(4):735-42.

PMID:
12377943
11.
12.

CD8+ cells in HIV infection produce macrophage inflammatory protein-1 alpha and RANTES: a comparative study in long-term survivors and progressor patients.

Zanussi S, D'Andrea M, Simonelli C, Battiston V, Tirelli U, De Paoli P.

Immunol Lett. 1996 Nov;53(2-3):105-8.

PMID:
9024986
13.

Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.

Mayanja-Kizza H, Wajja A, Wu M, Peters P, Nalugwa G, Mubiru F, Aung H, Vanham G, Hirsch C, Whalen C, Ellner J, Toossi Z.

J Infect Dis. 2001 Jun 15;183(12):1801-4. Epub 2001 May 17.

PMID:
11372034
15.

Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals.

Maggi E, Manetti R, Annunziato F, Cosmi L, Giudizi MG, Biagiotti R, Galli G, Zuccati G, Romagnani S.

Blood. 1997 May 15;89(10):3672-81.

16.

HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.

Casoli C, Vicenzi E, Cimarelli A, Magnani G, Ciancianaini P, Cattaneo E, Dall'Aglio P, Poli G, Bertazzoni U.

Blood. 2000 May 1;95(9):2760-9.

17.

HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.

Kinter AL, Ostrowski M, Goletti D, Oliva A, Weissman D, Gantt K, Hardy E, Jackson R, Ehler L, Fauci AS.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14076-81.

18.

Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.

Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G.

J Leukoc Biol. 2000 Sep;68(3):405-12.

PMID:
10985258
20.

Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

Heggelund L, Damås JK, Yndestad A, Holm AM, Mūller F, Lien E, Espevik T, Aukrust P, Frøland SS.

Clin Exp Immunol. 2004 Oct;138(1):116-21. Erratum in: Clin Exp Immunol. 2004 Dec;138(3):554.

Supplemental Content

Support Center